BioSpace News Archive

Medidata, a Dassault Systèmes company, global leader in creating end-to-end solutions to support the entire clinical trial process, announced that SHYFT Analytics will officially be adopting the Acorn AI, by Medidata brand

Seabrook, a non-profit, CARF-accredited, substance use and co-occurring disorder treatment provider, is proud to announce David P. Russo, MD, FACS as the new Medical Director.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase 3 trial of evinacumab in 65 patients with homozygous familial hypercholesterolemia (HoFH).

- In response to wildfires in California , Nevada and Oregon , and a powerful storm that caused widespread damage in Iowa , the governors of all four states have declared states of emergency for impacted counties. Blue Cross Blue Shield of Massachusetts (Blue Cross), Inc. is expediting access to care for members who may be affected.

NS Pharma, Inc. (NS Pharma; President, Tsugio Tanaka ), a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku; President, Shigenobu Maekawa ), announced today that VILTEPSO™ (viltolarsen) injection is now commercially available in the U.S. On August 12, 2020 , the U.S. Food & Drug Administration (FDA) approve

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Momenta Pharmaceuticals, Inc. (“MNTA” or the “Company”) (NASDAQ: MNTA) in conne

Announced today, Astiva Health reached a major milestone on its way to becoming a full-service Medicare Advantage Prescription Drug Health Plan (MAPD) serving both Orange and San Diego Counties in 2021.

Recently, the research project titled “Development of 1.5 T cryogen-free superconducting magnets” has achieved a phased breakthrough and the University of Nottingham Ningbo China (UNNC) is expected to introduce the world’s first 1.5T rotatable dual-gesture magnetic resonance imaging (MRI) scanner soon.

Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). The investigation concerns whether Regeneron and certain of its officers and/or directors have breached fiduciary duties owed to the company and its investors. If you are a shareholder of R

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofia® SARS Antigen FIA has been amended to include either nasal or nasopharyngeal swabs.